Matches in SemOpenAlex for { <https://semopenalex.org/work/W4207059079> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4207059079 endingPage "520" @default.
- W4207059079 startingPage "520" @default.
- W4207059079 abstract "Rosacea is a chronic inflammatory skin disease whose etiopathogenesis is still unknown. Previous studies have shown a relationship between certain inflammatory disorders and serum endocan levels. Endocan (previously known as endothelial cell-specific molecule 1) might play a role in the pathogenesis of various inflammatory diseases.Our study aimed to evaluate serum endocan levels in patients with rosacea to investigate the association of endocan with the demographic data.The study recruited individuals aged ≥18 years who voluntarily agreed to participate in the study. The participants included 37 women (mean age: 48.29 ± 12.08 years) and 13 men (mean age: 52.23 ± 13.34 years) diagnosed with rosacea, and 37 women (mean age: 49.18 ± 16.6 years) and 13 men (mean age: 53.69 ± 11.30 years) selected as controls. Both groups were matched according to age and sex. The rosacea diagnosis was based on clinical examination findings, and serum endocan levels were measured using the method of enzyme-linked immunosorbent assay (ELISA). The statistical significance of the data was determined by the Mann-Whitney U test, and a value of P < 0.05 was considered statistically significant.Serum endocan levels differed significantly between the patients with rosacea and the control group (P < 0.05).Circulating endocan might be a new marker related to disease progression in patients with rosacea. Further investigation is needed to determine whether endocan levels could become a new therapeutic target in rosacea, a disease that still cannot be fully cured." @default.
- W4207059079 created "2022-01-26" @default.
- W4207059079 creator A5000127115 @default.
- W4207059079 creator A5000842605 @default.
- W4207059079 creator A5038958407 @default.
- W4207059079 creator A5086602933 @default.
- W4207059079 date "2021-01-01" @default.
- W4207059079 modified "2023-10-01" @default.
- W4207059079 title "Elevated serum endocan levels in patients with rosacea: A new therapeutic target?" @default.
- W4207059079 cites W1500686316 @default.
- W4207059079 cites W1547942833 @default.
- W4207059079 cites W1656397836 @default.
- W4207059079 cites W1985145087 @default.
- W4207059079 cites W1993593532 @default.
- W4207059079 cites W1995046079 @default.
- W4207059079 cites W2001544048 @default.
- W4207059079 cites W2001649932 @default.
- W4207059079 cites W2020861620 @default.
- W4207059079 cites W2027534061 @default.
- W4207059079 cites W2030812638 @default.
- W4207059079 cites W2072248030 @default.
- W4207059079 cites W2083613396 @default.
- W4207059079 cites W2084996169 @default.
- W4207059079 cites W2108347444 @default.
- W4207059079 cites W2113024471 @default.
- W4207059079 cites W2163871403 @default.
- W4207059079 cites W2735624709 @default.
- W4207059079 cites W2803308785 @default.
- W4207059079 cites W2900757530 @default.
- W4207059079 cites W2902713005 @default.
- W4207059079 cites W2954957264 @default.
- W4207059079 cites W3022455098 @default.
- W4207059079 cites W3042564751 @default.
- W4207059079 doi "https://doi.org/10.4103/ijd.ijd_401_21" @default.
- W4207059079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35068507" @default.
- W4207059079 hasPublicationYear "2021" @default.
- W4207059079 type Work @default.
- W4207059079 citedByCount "0" @default.
- W4207059079 crossrefType "journal-article" @default.
- W4207059079 hasAuthorship W4207059079A5000127115 @default.
- W4207059079 hasAuthorship W4207059079A5000842605 @default.
- W4207059079 hasAuthorship W4207059079A5038958407 @default.
- W4207059079 hasAuthorship W4207059079A5086602933 @default.
- W4207059079 hasBestOaLocation W42070590791 @default.
- W4207059079 hasConcept C126322002 @default.
- W4207059079 hasConcept C16005928 @default.
- W4207059079 hasConcept C203014093 @default.
- W4207059079 hasConcept C2777673923 @default.
- W4207059079 hasConcept C2778081122 @default.
- W4207059079 hasConcept C2779134260 @default.
- W4207059079 hasConcept C2780942790 @default.
- W4207059079 hasConcept C65409693 @default.
- W4207059079 hasConcept C71924100 @default.
- W4207059079 hasConcept C90924648 @default.
- W4207059079 hasConceptScore W4207059079C126322002 @default.
- W4207059079 hasConceptScore W4207059079C16005928 @default.
- W4207059079 hasConceptScore W4207059079C203014093 @default.
- W4207059079 hasConceptScore W4207059079C2777673923 @default.
- W4207059079 hasConceptScore W4207059079C2778081122 @default.
- W4207059079 hasConceptScore W4207059079C2779134260 @default.
- W4207059079 hasConceptScore W4207059079C2780942790 @default.
- W4207059079 hasConceptScore W4207059079C65409693 @default.
- W4207059079 hasConceptScore W4207059079C71924100 @default.
- W4207059079 hasConceptScore W4207059079C90924648 @default.
- W4207059079 hasIssue "5" @default.
- W4207059079 hasLocation W42070590791 @default.
- W4207059079 hasLocation W42070590792 @default.
- W4207059079 hasLocation W42070590793 @default.
- W4207059079 hasLocation W42070590794 @default.
- W4207059079 hasOpenAccess W4207059079 @default.
- W4207059079 hasPrimaryLocation W42070590791 @default.
- W4207059079 hasRelatedWork W186837490 @default.
- W4207059079 hasRelatedWork W1972654344 @default.
- W4207059079 hasRelatedWork W2001455630 @default.
- W4207059079 hasRelatedWork W2027534061 @default.
- W4207059079 hasRelatedWork W2411809640 @default.
- W4207059079 hasRelatedWork W2435105114 @default.
- W4207059079 hasRelatedWork W3025180407 @default.
- W4207059079 hasRelatedWork W3030862218 @default.
- W4207059079 hasRelatedWork W4361835646 @default.
- W4207059079 hasRelatedWork W1817386941 @default.
- W4207059079 hasVolume "66" @default.
- W4207059079 isParatext "false" @default.
- W4207059079 isRetracted "false" @default.
- W4207059079 workType "article" @default.